Published in

Wiley, American Journal of Hematology, 9(96), p. 1120-1130, 2021

DOI: 10.1002/ajh.26261

Links

Tools

Export citation

Search in Google Scholar

Selinexor, bortezomib, and dexamethasone versus bortezomib and dexamethasone in previously treated multiple myeloma: Outcomes by cytogenetic risk

Journal article published in 2021 by Shambavi Richard ORCID, Ajai Chari, Sosana Delimpasi, Maryana Simonova, Ivan Spicka, Ludek Pour, Iryna Kriachok, Meletios A. Dimopoulos ORCID, Halyna Pylypenko, Holger W. Auner ORCID, Xavier Leleu, Ganna Usenko, Roman Hajek, Reuben Benjamin ORCID, Tuphan Kanti Dolai and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO